S_mmimary Hereditary non-polyposis colorectal cancer (HNPCC) has recently been linked to germline defects of DNA repair genes. Colorectal tumours in HNPCC frequently show DNA microsatellite instability, but it is not certain whether this mutator phenotype occurs throughout the morphologically normal colonic mucosa. We have previously used the mPAS histochemical technique in human colorectal mucosa to identify a polymorphism for O-acetyltransferase activity that shows monogenic inheritance and to show that cryptrestricted loss of O-acetyltransferase activity in heterozygotes is due to somatic mutation. We have now used this histochemical technique to measure the somatic mutation frequency in the uninvolved colon of 12 heterozygous patients with HNPCC, 15 with ileocaecal Crohn's disease and 16 with sporadic colorectal cancer (CRC). HNPCC patients showed a significant increase in mutation frequency with age (Mann-Whitney U. P=0.02). In HNPCC patients aged <49 years the mean stem cell mutation frequency was significantly lower than in the slightly younger group of patients with Crohn's disease (0.8 ± 0.9 x 10-' vs 3.5 ± 3.3 x 10-4, P<0.01), probably reflecting an increased mutation rate relating to chronic mucosal damage in Crohn's disease. Although not statistically significant, the stem cell mutation frequency was slightly less in HNPCC patients >50 years than in sporadic CRC cases (4.9 ± 3.4 x 10-4vs 5.9 ± 3.6 x 10-4, P>0.5 al., 1993).
Colorectal carcinoma (CRC) is known to occur as a familial tumour as part of two distinct syndromes, familial adenomatous polyposis (FAP) and hereditary non-polyposis colorectal cancer (HNPCC) . The gene for FAP (APC) has been identified on chromosome 5q21 (KinzAer et al., 1991) , and inheritance of a mutated allele is associated with the development during the second or third decade of life of very many colorectal adenomas, a small number of which are highly likely to progress to adenocarcinoma in early to mid adult life. HNPCC appears to be a more genetically heterogeneous condition, in that inherited abnormalities of at least four genes on chromosomes 2p , 2q (Nicolaides et al., 1994) , 3p (Lindblom et al., 1993) and 7p (Nicolaides et al., 1994) appear to be involved in different kindreds. CRC in HNPCC usually presents later in life than in FAP, and is more often right-sided, more frequently diploid or near-diploid and possibly more often of mucinous or signet ring cell type than sporadic CRC . While multiple carcinomas may occur, the background bowel rarely contains more than a few adenomas, although these are often larger and are claimed to be more prone to malignant progression than their sporadic counterparts (Jass and Stewart, 1992) . Extracolonic tumours occur in both FAP and HNPCC patients, notably adenomas and carcinomas of the more proximal gastrointestinal tract, desmoid tumours, thyroid, brain and liver tumours in FAP (Phillips et al., 1994) and endometrial, gastric, ovarian and urinary tract carcinomas in HNPCC .
The APC gene is thought to act as a tumour-suppressor gene and, although the function of its product is not established, there is evidence to suggest that it is involved in cell adhesion (Su et al., 1993) . The four putative HNPCC genes so far identified, on the other hand, appear to be involved in DNA repair. Colorectal adenomas and carcinomas, and extracolonic carcinomas, of HNPCC patients show a high frequency of DNA microsatellite instability (Aaltonen et al., 1994) , and human homologues of the prokaryotic DNA mismatch repair genes mutS and mutL map to the regions of chromosomes 2, 3 and 7 that have been shown by linkage studies to bear the HNPCC loci. Moreover, germline mutations of these repair genes occur in affected patients (Fishel et al., 1993; Leach et al., 1993; Bronner et al., 1994; Nicolaides et al., 1994) . HNPCC patients might therefore be expected to show an increased frequency of somatic mutation in a wide range of other genes. Loss of heterozygosity for chromosomes 2 or 3 is not common in HNPCC tumours Lindblom et al., 1993) and it is not certain whether the gene is acting dominantly, conferring increased mutation in the normal colon as well as in tumours, or whether its action is confined to tumours. Evidence suggesting-the latter is derived from the fact that a lymphoblastoid cell line from an HNPCC-affected individual was proficient in mismatch repair and that normal tissue (of unspecified type) from HNPCC patients was not found to show microsatellite instability . However, the possibility that the inherited DNA defect is confined to tissues with an increased incidence of cancer, e.g. colonic mucosa, is not excluded. We have therefore set out to determine whether the somatic mutation rate is increased in the morphologically normalappearing colon of HNPCC patients.
We have shown that a polymorphism exists in human colon for the O-acetylation of sialic acid in mucus glycoproteins which can be demonstrated in tissue sections using mPAS histochemistry (Fuller et al., 1990; Campbell et al., 1994a) . This technique, which is a modification of the periodic-acid Schiff procedure, allows non-O-acetylated sialomucins to be distinguished from O-acetylated sialomucins (Veh et al., 1992 (Fuller et al., 1990; Campbell et al., 1994b (Campbell et al., 1994b) . We have therefore quantified the frequency of discordant crypts in microscopically normal colon from patients with HNPCC, and compared this with their frequency in uninvolved colon from patients with either Crohn's disease (for younger HNPCC patients) or sporadic right-sided CRC (for older HNPCC patients). These two groups were chosen for the comparison because of the unavailability of an adequate number of right-sided colonic resection specimens from normal individuals with a wide age range.
Materials and methods
Twenty six HNPCC patients who had undergone large bowel resection for CRC were identified from registers maintained in Cambridge and Cardiff. They were derived from a total of 19 families, and all satisfied the Amsterdam criteria for a diagnosis of HNPCC (Vasen et al., 1991) with (a) three or more relatives with histologically verified CRC, one of whom is a first-degree relative of the other two (b) CRC involving at least two generations and (c) one or more CRCs diagnosed before the age of 50 years. In 19 cases the CRC occurred proximal to the splenic flexure. None of the patients had been treated with radiotherapy or chemotherapy. Paraffin blocks from these HNPCC specimens, from 32 right hemicolectomy specimens for ileocaecal Crohn's disease and from 40 consecutive hemicolectomy specimens for sporadic primary right-sided CRC collected prospectively were retrieved from departmental files. None of these patients had received radiotherapy or cancer chemotherapy, but two of the Crohn's disease patients had received the mutagen azathioprine for immunosuppression.
Blocks of uninvolved microscopically normal colonic resection margin mucosa were selected and 5 Lm step sections, cut at 80 pm intervals apart, were stained by the mPAS reaction (Veh et al., 1982) . In this technique the oxidation step of a standard periodic acid-Schiff reaction is modified (using 1 mM sodium periodate at 4"C for 10 min) (Vogel and Motulsky, 1986 ) using the x2 test as described previously (Campbell et al., 1994a) and the frequencies of discordant (mutated) crypts in each group were compared using the Mann-Whitney U-test.
Results Table I shows the age, sex and mPAS phenotype distributions in the three patient groups studied. As would be expected, patients undergoing right hemicolectomy for Crohn's disease were significantly younger than those with sporadic CRC, while patients with HNPCC had a broad age range. The frequency distribution of the three mPAS phenotypes was similar in alt three patient groups, and showed no significant difference (z, P>0.9) from that predicted by the Hardy-Weinberg law for a single polymorphic gene. Table II shows the frequencies of discordant (mutated) crypts in patients with scattered mPAS-positive crypts in a predominantly mPAS-negative background, i.e. those patients considered to be heterozygous for O-acetyltransferase activity and therefore informative for measuring the frequency of somatic mutation. Since HNPCC patients showed a much wider age range than the other two groups, they have also been divided into those aged <49 years and those >50 years. This is particularly important for the comparison of wholly mutated crypt frequencies because they result from fixed stem cell mutations and reflect the lifetime accumulated mutational load (Campbell et al., 1994b) .
In informative HNPCC patients the total frequency of mutated crypts ranged from 0.7 x 10-4 to 12.7 x 10-4. The mean frequency in the five patients aged 28-48 years was 1.5 ± 0.8 x 10-4 (median 1.0 x 10-4), and in the seven patients aged 51-80 years it was 6.3 4.3 x 10-4 (median 4.3 x 10-4), a significant difference (Mann-Whitney U, P = 0.02) that was largely accounted for by a difference in the frequencies of wholly involved crypts (P = 0.01). The frequency of partially involved crypts was not significantly different in the two age groups. Informative patients with Crohn's disease were aged years (median 27 years) and had total mutated crypt frequencies ranging from 0.9 x 10-4 to 15.5 x 10-4 with a mean of 4.2 ± 4.0 x 10-4 and a median of 3.1 x 10-4. However the two highest frequencies (15.5 x 10-4 in a 36-year old and 8.0 x 10-4 in a 26-year old) were found in the two patients who had received preoperative azathioprine treatment. Comparison of the discordant crypt frequencies in all 15 informative Crohn's disease patients with the similarly aged younger group of five HNPCC cases shows a significantly higher frequency of wholly involved crypts in the Crohn's disease group (P<0.01), but not of partially involved crypts (P>0.3). Even when the two azathioprine-treated patients are excluded the difference for wholly involved crypts remains significant (P<0.02).
The 16 informative patients with sporadic right-sided CRC were aged 62-94 years (median 75 years). Their mean total mutated crypt frequency was 6.6 ± 4.0 x 10-4 (median 6.1 x 10-4), ranging from 0.5 to 12.0 x 10-4. Comparison of the discordant crypt frequencies in these cases with all 12 HNPCC cases showed a significantly increased frequency of wholly mutated crypts in those with sporadic CRC (P<0.05). However, this difference can be attributed to the different ages of the patients in the two groups. When the comparison is confined to the seven HNPCC patients aged >50 years (median 56 years) the statistical significance of the difference disappears (P = 0.5). No significant difference was found in the frequencies of partially involved discordant crypts between HNPCC and sporadic CRC patients.
The main finding in this study is that the somatic mutation frequency in the non-tumorous background colonic mucosa of patients with HNPCC, as assessed by mPAS histochemistry, is not significantly raised when compared with agematched patients with sporadic right-sided CRC, and is significantly lower than that found in age-matched patients with Crohn's disease when assessed by the frequency of accumulated stem cell mutations (i.e. wholly involved discordant crypts). Our findings therefore support those of molecular studies in other tissues derived from HNPCC patients, and suggest that there is no generalised tissuespecific mutator phenotype in the colonic epithelium, the cell lineage in which most tumours arise in this inherited cancer syndrome. However, we cannot exclude the possibility that the gene responsible for O-acetyltransferase activity is mutated by a different mechanism from that relevant to HNPCC. The fact that the colonic mutation frequency in the young (<49 years) group of HNPCC patients was lower than in age-matched Crohn's disease patients suggests that it may represent the 'normal' cumulative mutation frequency at this age. While it is possible that the sporadic CRC group contains unrecognised HNPCC cases, we believe that this is unlikely to have had a major influence on the findings because the age distribution and frequency of somatic mutation in our patients with right-sided CRC were not significantly different from a previously reported group of rectal cancer patients (Campbell et al., 1994b) .
Since germline defects of the various genes resulting in HNPCC syndromes do not by themselves lead to a detectable generalised increased mutation frequency in the colon, a second event is needed to trigger the cascade of events leading to carcinogenesis. This is presumably a mutation in another gene which, together with the inherited mutation, allows expression of the increased liability to mutation. The nature of the second mutation can only be a matter for speculation at present. The simple explanation, that it is a somatically acquired defect in the second allele leading to loss of function of the HNPCC gene, has been questioned because loss of heterozygosity (LOH) of linked markers for the relevant chromosome loci is not a frequent finding in HNPCC tumours Lindblom et al., 1993) . However, somatic point mutation of the second (wildtype) allele has been descnbed in two CRCs in HNPCC patients with germline mutations of either mutL or mutS homologues Nicolaides et al., 1994) , indicating that this could still be an important route for acquiring the mutator phenotype. Another possibility is that liability to increased mutation requires somatic mutation of a second gene for its expression . If the presumptive second mutation were to occur at the same frequency as the mutation we have observed in this study, this would imply that by the age of 50 years only some three or four crypts in every 10 000 would have acquired an increased somatic mutation rate. This would not be a sufficiently common event to be detectable by current methods of estimating somatic mutation rates in vivo. However, it could well be sufficient to result in the increased frequency of CRC in HNPCC patients, particularly when it is remembered that an accelerated mutation rate is likely to increase the chance of mutation in other DNA repair genes with a cascade effect.
The finding of an increased somatic mutation frequency in the colons of Crohn's disease patients is of interest, and is probably related to increased regenerative epithelial proliferation in chronic colitis. It is likely to be related to the known increased risk of colorectal cancer in chronic inflammatory bowel disease, both Crohn's colitis and ulcerative colitis (Gillen et al., 1994) . The fact that the highest mutation frequencies in Crohn's disease patients occurred in the two who had received azathioprine would be predicted from treatment with a known mutagen, and raises concerns that azathioprine therapy may add to the carcinogenic risk in inflammatory bowel disease. A recent retrospective study of Somatiic mubtio in HNPC OO-GT Wdhams et a 1,0 long-term neoplasia risk after azathioprine treatment in patients with Crohn's disease and ulcerative colitis (Connell et al., 1994) found a significant 2.5 fold increase in all neoplasms after more than 5 years of azathioprine, and a 17-fold increase in CRC, although this did not reach statistical significance (the absolute number of tumours was small). The same study compared the frequency of CRC in azathioprine-treated ulcerative colitis patients with matched patients who had not received the drug. Only a small nonsignificant increase was observed in the treated group, but this included an unspecified proportion of patients with short treatment times. Further studies of the risks of long-term azathioprine therapy are needed.
Our observations can be correlated with the clinical findings in FAP and HNPCC. The high frequency of colonic adenomas in FAP is consistent with a single somatic mutation of the normal allele of the APC gene leading to adenoma formation in these patients. These adenomas individually have a relatively low risk of progression to malignancy but they are so numerous that malignancy is virtually certain to occur in one or more polyps during the lifetime of an FAP patient. The infrequency of adenomas in HNPCC patients suggests that a single somatic mutation is not sufficient, but that at least two events are needed for adenoma formation. Our findings show that there is no general increase in somatic mutation, and are compatible with a sequence of events in which a single somatic mutation leads to an increased propensity to somatic mutation in the involved crypt only. A significant proportion of these 'mutation-prone' crypts then acquire the further events needed to give rise to an adenoma, also mutation prone, and with a high chance of progression to malignancy. This hypothesis is supported by the high frequency of microsatellite instability in both adenomas and carcinomas in HNPCC (Aaltonen et al., 1994) , and by the suggestion that adenomas in these patients are more prone to malignant progression than sporadic adenomas or those of FAP (Jass and Stewart, 1992) .
